Nektar Therapeutics
NKTR
#4816
Rank
A$2.71 B
Marketcap
A$96.90
Share price
4.67%
Change (1 day)
403.27%
Change (1 year)

Nektar Therapeutics (NKTR) - Cash on Hand

Cash on Hand as of September 2025 : A$0.37 Billion

According to Nektar Therapeutics 's latest financial reports the company has A$0.37 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Nektar Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.41 B-7.92%
2023-12-31A$0.44 B-39.95%
2022-12-31A$0.74 B-26.7%
2021-12-31A$1.01 B-26.69%
2020-12-31A$1.38 B-27.02%
2019-12-31A$1.89 B-0.17%
2018-12-31A$1.89 B399.72%
2017-12-31A$0.37 B-29.73%
2016-12-31A$0.53 B27.29%
2015-12-31A$0.42 B45.94%
2014-12-31A$0.29 B9.36%
2013-12-31A$0.26 B-0.38%
2012-12-31A$0.26 B13.41%
2011-12-31A$0.23 B-24.38%
2010-12-31A$0.31 B-29.48%
2009-12-31A$0.44 B-17.89%
2008-12-31A$0.53 B-2.63%
2007-12-31A$0.55 B-5.17%
2006-12-31A$0.58 B-10.6%
2005-12-31A$0.65 B20.27%
2004-12-31A$0.54 B40.65%
2003-12-31A$0.38 B-26.27%
2002-12-31A$0.52 B-22.67%
2001-12-31A$0.67 B-22.19%
2000-12-31A$0.86 B312.37%
1999-12-31A$0.21 B55.39%
1998-12-31A$0.13 B-11.99%
1997-12-31A$0.15 B556.69%
1996-12-31A$23.41 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$28.23 B 7,339.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$21.04 B 5,445.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.26 B 3,395.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$2.76 B 627.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$25.58 B 6,640.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$8.06 B 2,024.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$46.55 M-87.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$1.56 B 311.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland